The non-rise in SP is very disappointing and reminds me of Nasdaq.
However if you follow biotechs, you will note that there could be massive gap-ups if trial results are very good. The current non-rise is SP is because buyers are waiting on the sidelines. They could miss out on the gap up. Historically there has been no leaky-boat with PRR.
I am now hoping that we have a massive gap-up when results are announced. Things could change in a second upon announcement.
Brainy
The non-rise in SP is very disappointing and reminds me of...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |